Publication: PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors
PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors
Date
Date
Date
Citations
Gabryś, H. S., Basler, L., Burgermeister, S., Hogan, S., Ahmadsei, M., Pavic, M., Bogowicz, M., Vuong, D., Tanadini-Lang, S., Förster, R., Kudura, K., Huellner, M., Dummer, R., Levesque, M. P., & Guckenberger, M. (2022). PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors. Frontiers in Oncology, 12, 977822. https://doi.org/10.3389/fonc.2022.977822
Abstract
Abstract
Abstract
PurposeThis study evaluated pretreatment 2[18F]fluoro-2-deoxy-D-glucose (FDG)-PET/CT-based radiomic signatures for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibition (ICI).Material and methodFifty-six consecutive metastatic melanoma patients treated with ICI and available imaging were included in the study and 330 metastatic lesions were individually, fully segmented on pre-treatment CT and FDG-PET imaging. Lesion hyperprogression (HPL) was defined as lesion progression according t
Metrics
Downloads
Views
Additional indexing
Creators (Authors)
Volume
Volume
Volume
Page range/Item number
Page range/Item number
Page range/Item number
Item Type
Item Type
Item Type
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Keywords
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Free Access at
Free Access at
Free Access at
Publisher DOI
Metrics
Downloads
Views
Citations
Gabryś, H. S., Basler, L., Burgermeister, S., Hogan, S., Ahmadsei, M., Pavic, M., Bogowicz, M., Vuong, D., Tanadini-Lang, S., Förster, R., Kudura, K., Huellner, M., Dummer, R., Levesque, M. P., & Guckenberger, M. (2022). PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors. Frontiers in Oncology, 12, 977822. https://doi.org/10.3389/fonc.2022.977822